Search

Your search keyword '"Lever, N."' showing total 237 results
Start Over Author "Lever, N."
237 results on '"Lever, N."'

1. Trauma-Focused Cognitive Behavioral Therapy in 13 Urban Public Schools: Mixed Methods Results of Barriers, Facilitators, and Implementation Outcomes

Author

Connors, E. H., Prout, J., Vivrette, R., Padden, J., and Lever, N.

Abstract

Trauma-focused cognitive behavioral therapy (TF-CBT) is an evidence-based intervention to treat post-traumatic stress disorder among youth ages 3-18 years old. In this pilot study, 31 clinicians in 13 urban public schools received TF-CBT training to improve access to high-quality trauma treatment for youth in need. A mixed methods design was used to assess implementation barriers, facilitators, and outcomes to examine initial feasibility, acceptability, and appropriateness of TF-CBT delivered in school settings. Although 70% of clinicians reported confidence in the evidence-base of TF-CBT and its potential to support their students who have a very high prevalence of lifetime trauma exposure, implementation practice outcomes suggest a wide range of TF-CBT use (range = 0-11 students enrolled per clinician, mean = 1.4 students) with 23 clinicians implementing the TF-CBT model with at least one case. Results point to the potential value of training school mental health clinicians in TF-CBT based on its compatibility with student needs. Yet, by connecting focus group results to top-rated barriers and facilitators, we identify several adjustments that should be made to improve intervention-setting fit in future studies. Specifically, school setting-specific intervention adaptations, school-tailored implementation support, and thoughtful consideration of school-based clinicians' roles and responsibilities are needed to enhance future implementation success.

Published
2021
Full Text
View/download PDF

5. Electrophysiology and 3D‐imaging reveal properties of human intracardiac neurons and increased excitability with atrial fibrillation

Author

Ashton, J. L., primary, Prince, B., additional, Sands, G., additional, Argent, L., additional, Anderson, M., additional, Smith, J. E. G., additional, Tedoldi, A., additional, Ahmad, A., additional, Baddeley, D., additional, Pereira, A. G., additional, Lever, N., additional, Ramanathan, T., additional, Smaill, B. H., additional, and Montgomery, Johanna M., additional

Published
2024
Full Text
View/download PDF

6. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections - Endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Author

Blomstrom-Lundqvist, C, Traykov, V, Erba, P, Burri, H, Nielsen, J, Bongiorni, M, Poole, J, Boriani, G, Costa, R, Deharo, J, Epstein, L, Saghy, L, Snygg-Martin, U, Starck, C, Tascini, C, Strathmore, N, Kalarus, Z, Boveda, S, Dagres, N, Rinaldi, C, Biffi, M, Geller, L, Sokal, A, Birgersdotter-Green, U, Lever, N, Tajstra, M, Kutarski, A, Rodriguez, D, Hasse, B, Zinkernagel, A, Mangoni, E, Blomstrom-Lundqvist C., Traykov V., Erba P. A., Burri H., Nielsen J. C., Bongiorni M. G., Poole J., Boriani G., Costa R., Deharo J. -C., Epstein L. M., Saghy L., Snygg-Martin U., Starck C., Tascini C., Strathmore N., Kalarus Z., Boveda S., Dagres N., Rinaldi C. A., Biffi M., Geller L., Sokal A., Birgersdotter-Green U., Lever N., Tajstra M., Kutarski A., Rodriguez D. A., Hasse B., Zinkernagel A., Mangoni E., Blomstrom-Lundqvist, C, Traykov, V, Erba, P, Burri, H, Nielsen, J, Bongiorni, M, Poole, J, Boriani, G, Costa, R, Deharo, J, Epstein, L, Saghy, L, Snygg-Martin, U, Starck, C, Tascini, C, Strathmore, N, Kalarus, Z, Boveda, S, Dagres, N, Rinaldi, C, Biffi, M, Geller, L, Sokal, A, Birgersdotter-Green, U, Lever, N, Tajstra, M, Kutarski, A, Rodriguez, D, Hasse, B, Zinkernagel, A, Mangoni, E, Blomstrom-Lundqvist C., Traykov V., Erba P. A., Burri H., Nielsen J. C., Bongiorni M. G., Poole J., Boriani G., Costa R., Deharo J. -C., Epstein L. M., Saghy L., Snygg-Martin U., Starck C., Tascini C., Strathmore N., Kalarus Z., Boveda S., Dagres N., Rinaldi C. A., Biffi M., Geller L., Sokal A., Birgersdotter-Green U., Lever N., Tajstra M., Kutarski A., Rodriguez D. A., Hasse B., Zinkernagel A., and Mangoni E.

Abstract

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.

Published
2020

7. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Author

Blomstrom-Lundqvist, C., Traykov, V., Erba, P. A., Burri, H., Nielsen, J. C., Bongiorni, M. G., Poole, J., Boriani, G., Costa, R., Deharo, J. -C., Epstein, L. M., Saghy, L., Snygg-Martin, U., Starck, C., Tascini, C., Strathmore, N., Kalarus, Z., Boveda, S., Dagres, N., Rinaldi, C. A., Biffi, M., Geller, L., Sokal, A., Birgersdotter-Green, U., Lever, N., Tajstra, M., Kutarski, A., Rodriguez, D. A., Hasse, B., Zinkernagel, A., Mangoni, E., Uppsala Universitet [Uppsala], Tokuda Hospital Sofia, University of Pisa - Università di Pisa, University Medical Center Groningen [Groningen] (UMCG), Aarhus University Hospital, Biorobotics Lab (University of Washington), University of Washington [Seattle], Università degli Studi di Modena e Reggio Emilia, Universidade Paulista [São Paulo] (UNIP), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Département de Cardiologie [Hôpital de la Timone - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE)-Assistance Publique - Hôpitaux de Marseille (APHM), Hofstra University [Hempstead], University of Szeged [Szeged], Department of Image Processing and Computer Graphics [Univ Szeged], University of Gothenburg (GU), West German Heart Center, Universität Duisburg-Essen [Essen], University Parthenope of Naples, The Royal Melbourne Hospital, Clinical sciences, Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Universität Duisburg-Essen = University of Duisburg-Essen [Essen], Università degli Studi di Napoli 'Parthenope' = University of Naples (PARTHENOPE), Blomstrom-Lundqvist, C, Traykov, V, Erba, P, Burri, H, Nielsen, J, Bongiorni, M, Poole, J, Boriani, G, Costa, R, Deharo, J, Epstein, L, Saghy, L, Snygg-Martin, U, Starck, C, Tascini, C, Strathmore, N, Kalarus, Z, Boveda, S, Dagres, N, Rinaldi, C, Biffi, M, Geller, L, Sokal, A, Birgersdotter-Green, U, Lever, N, Tajstra, M, Kutarski, A, Rodriguez, D, Hasse, B, Zinkernagel, A, and Mangoni, E

Subjects
Leads, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Extraction, 030204 cardiovascular system & hematology, law.invention, Defibrillator, 0302 clinical medicine, Randomized controlled trial, law, Health care, Cardiac and Cardiovascular Systems, Endocarditi, 03.02. Klinikai orvostan, 030212 general & internal medicine, Antibiotic prophylaxis, Cardiac resynchronization therapy, Device, Pacemaker, Infection, Kardiologi, Re-implantation, Endocarditis, Latin America/epidemiology, Cardiac implantable electronic device, TRANSVENOUS LEAD EXTRACTION, Defibrillators, Implantable/adverse effects, Thoracic Surgery, General Medicine, STAPHYLOCOCCUS-AUREUS BACTEREMIA, F-18-FDG PET/CT, Defibrillators, Implantable, SINGLE-CENTER EXPERIENCE, 3. Good health, Cardiac implantable electronic devices, EHRA consensus document, Implantable cardioverter-defibrillators, Microbiology, Pacemakers, Cardiothoracic surgery, Risk assessment, Cardiology and Cardiovascular Medicine, EHRA Position Paper, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Asia, Consensus, PERMANENT PACEMAKER IMPLANTATION, CARDIOVERTER-DEFIBRILLATOR IMPLANTATION, Infections, Communicable Diseases, Implantable cardioverter-defibrillator, 03 medical and health sciences, LONG-TERM COMPLICATIONS, ANTIBIOTIC-PROPHYLAXIS, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Infections/diagnosis, Physiology (medical), medicine, Humans, Intensive care medicine, SURGICAL-SITE, business.industry, Cardiac Resynchronization Therapy Devices, Latin America, Lead, RISK-FACTORS, Artificial cardiac pacemaker, Surgery, Electronics, Implantable cardioverterdefibrillators, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections. This article is simultaneously published also in Eur J Cardiothorac Surg. (https://doi.org/10.1093/ejcts/ezz296) and European Heart Journal (https://doi.org/10.1093/eurheartj/ehaa010). Minor differences in style may appear in each publication, but the article is substantially the same in each journal.

Published
2019
Full Text
View/download PDF

22. Evaluation of Early Allograft Function in Donor HCV-Positive to Recipient HCV-Negative Cardiac Transplantation Managed with Preemptive Direct Acting Antiviral Therapy

Author

Lebeis, T.A., primary, Afari, M.E., additional, Bethea, E.D., additional, Gaj, K., additional, Gustafson, J.L., additional, Turvey, K., additional, Coglianese, E., additional, Thomas, S.S., additional, Newton-Cheh, C., additional, Ibrahim, N., additional, Carlson, W.D., additional, Ho, J.E., additional, Nayor, M., additional, Steiner, J.K., additional, Spahillari, A., additional, Villavicencio-Theoduloz, M.A., additional, D'Alessandro, D.A., additional, Soydara, C., additional, Lever, N., additional, Chung, R.T., additional, and Lewis, G.D., additional

Published
2019
Full Text
View/download PDF

24. Baseline brain function in the preadolescents of the ABCD Study

Author

Chaarani, B., Hahn, S., Allgaier, N., Adise, S., Owens, M. M., Juliano, A. C., Yuan, D. K., Loso, H., Ivanciu, A., Albaugh, M. D., Dumas, J., Mackey, S., Laurent, J., Ivanova, M., Hagler, D. J., Cornejo, M. D., Hatton, S., Agrawal, A., Aguinaldo, L., Ahonen, L., Aklin, W., Anokhin, A. P., Arroyo, J., Avenevoli, S., Babcock, D., Bagot, K., Baker, F. C., Banich, M. T., Barch, D. M., Bartsch, H., Baskin-Sommers, A., Bjork, J. M., Blachman-Demner, D., Bloch, M., Bogdan, R., Bookheimer, S. Y., Breslin, F., Brown, S., Calabro, F. J., Calhoun, V., Casey, B. J., Chang, L., Clark, D. B., Cloak, C., Constable, R. T., Constable, K., Corley, R., Cottler, L. B., Coxe, S., Dagher, R. K., Dale, A. M., Dapretto, M., Delcarmen-Wiggins, R., Dick, A. S., Do, E. K., Dosenbach, N. U. F., Dowling, G. J., Edwards, S., Ernst, T. M., Fair, D. A., Fan, C. C., Feczko, E., Feldstein-Ewing, S. W., Florsheim, P., Foxe, J. J., Freedman, E. G., Friedman, N. P., Friedman-Hill, S., Fuemmeler, B. F., Galvan, A., Gee, D. G., Giedd, J., Glantz, M., Glaser, P., Godino, J., Gonzalez, M., Gonzalez, R., Grant, S., Gray, K. M., Haist, F., Harms, M. P., Hawes, S., Heath, A. C., Heeringa, S., Heitzeg, M. M., Hermosillo, R., Herting, M. M., Hettema, J. M., Hewitt, J. K., Heyser, C., Hoffman, E., Howlett, K., Huber, R. S., Huestis, M. A., Hyde, L. W., Iacono, W. G., Infante, M. A., Irfanoglu, O., Isaiah, A., Iyengar, S., Jacobus, J., James, R., Jean-Francois, B., Jernigan, T., Karcher, N. R., Kaufman, A., Kelley, B., Kit, B., Ksinan, A., Kuperman, J., Laird, A. R., Larson, C., LeBlanc, K., Lessov-Schlagger, C., Lever, N., Lewis, D. A., Lisdahl, K., Little, A. R., Lopez, M., Luciana, M., Luna, B., Madden, P. A., Maes, H. H., Makowski, C., Marshall, A. T., Mason, M. J., Matochik, J., McCandliss, B. D., McGlade, E., Montoya, I., Morgan, G., Morris, A., Mulford, C., Murray, P., Nagel, B. J., Neale, M. C., Neigh, G., Nencka, A., Noronha, A., Nixon, S. J., Palmer, C. E., Pariyadath, V., Paulus, M. P., Pelham, W. E., Pfefferbaum, D., Pierpaoli, C., Prescot, A., Prouty, D., Puttler, L. I., Rajapaske, N., Rapuano, K. M., Reeves, G., Renshaw, P. F., Riedel, M. C., Rojas, P., de la Rosa, M., Rosenberg, M. D., Ross, M. J., Sanchez, M., Schirda, C., Schloesser, D., Schulenberg, J., Sher, K. J., Sheth, C., Shilling, P. D., Simmons, W. K., Sowell, E. R., Speer, N., Spittel, M., Squeglia, L. M., Sripada, C., Steinberg, J., Striley, C., Sutherland, M. T., Tanabe, J., Tapert, S. F., Thompson, W., Tomko, R. L., Uban, K. A., Vrieze, S., Wade, N. E., Watts, R., Weiss, S., Wiens, B. A., Williams, O. D., Wilbur, A., Wing, D., Wolff-Hughes, D., Yang, R., Yurgelun-Todd, D. A., Zucker, R. A., Potter, A., and Garavan, H. P.

Abstract

The Adolescent Brain Cognitive Development (ABCD) Study®is a 10-year longitudinal study of children recruited at ages 9 and 10. A battery of neuroimaging tasks are administered biennially to track neurodevelopment and identify individual differences in brain function. This study reports activation patterns from functional MRI (fMRI) tasks completed at baseline, which were designed to measure cognitive impulse control with a stop signal task (SST; N= 5,547), reward anticipation and receipt with a monetary incentive delay (MID) task (N= 6,657) and working memory and emotion reactivity with an emotional N-back (EN-back) task (N= 6,009). Further, we report the spatial reproducibility of activation patterns by assessing between-group vertex/voxelwise correlations of blood oxygen level-dependent (BOLD) activation. Analyses reveal robust brain activations that are consistent with the published literature, vary across fMRI tasks/contrasts and slightly correlate with individual behavioral performance on the tasks. These results establish the preadolescent brain function baseline, guide interpretation of cross-sectional analyses and will enable the investigation of longitudinal changes during adolescent development.

Published
2021
Full Text
View/download PDF

27. Valeurs de certains paramètres prosodiques obtenues auprès de sujets francophones sans trouble de la communication

Author

Le Dorze G, Ryalls J, Lever N, and Brassard C

Subjects
Speech and Hearing, Linguistics and Language, Measurement method, Intonation (music), LPN and LVN, Prosody, Psychology, Humanities, Language and Linguistics
Abstract

Des donnees acoustiques sont proposees pour faciliter l’valuation de la parole de patients presentant des troubles de la prosodie tels la dysarthrie. Ces donnees ont ete recueillies aupres de 40 sujet

Published
1995
Full Text
View/download PDF

28. PROLONGED TEMPORARY PACING USING TUNNELLED LEADS: A BRIDGE TO PERMANENT PACING IN SEVERE SEPSIS

Author

Lever, N, Ferguson, J D., Bashir, Y, and Channon, K M.

Subjects
Cardiac pacing -- Methods, Bradycardia -- Care and treatment, Health, Care and treatment, Methods
Abstract

Background: In patients with bradycardia, severe sepsis requiring prolonged antibiotic therapy precludes early permanent pacing. Traditional temporary pacing techniques are unsatisfactory. Transvenous leads require replacement every 5-7 days due to [...]

Published
2001

29. CARDIOVERSION OF ATRIAL FIBRILLATION IN OCTOGENARIANS USING TRANSOESOPHAGEAL ECHO GUIDANCE AND AN ABBREVIATED DOMICILIARY LOW-MOLECULAR-WEIGHT HEPARIN PROTOCOL

Author

Lever, N, Ferguson, J D., Banning, A P., and Bashir, Y

Subjects
Heparin -- Health aspects -- Physiological aspects, Atrial fibrillation -- Physiological aspects -- Health aspects, Cardiac patients -- Physiological aspects -- Health aspects, Health, Physiological aspects, Health aspects
Abstract

Methods: We recruited 16 consecutive pts (80-91 years, 9M:7F) with persistent AF (median duration 88[6-230] days) who had previously been turned down for cardioversion with standard anticoagulation. They underwent TOE [...]

Published
2001

30. TEMPORARY DUAL CHAMBER PACING IN PATIENTS WITH HEART FAILURE AND HYPOTENSION: IS THERE SIGNIFICANT HAEMODYNAMIC BENEFIT?

Author

Ferguson, J D., Lever, N, Channon, K M., and Bashir, Y

Subjects
Cardiac pacing -- Research, Bradycardia -- Care and treatment -- Research, Heart failure -- Care and treatment -- Research, Health, Care and treatment, Research
Abstract

Temporary dual chamber (DDD) pacing is theoretically beneficial in patients with bradyarrhythmia and heart failure, but there is currently insufficient data to justify this potentially complex procedure in emergency settings. [...]

Published
2001

31. A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomised controlled trial (the Minimax Study)

Author

McLellan, A., primary, Ling, L., additional, Azzopardi, S., additional, Lee, G., additional, Kumar, S., additional, Wong, M., additional, Walters, T., additional, Lee, J., additional, Halloran, K., additional, Stiles, M., additional, Lever, N., additional, Fynn, S., additional, Heck, P., additional, Sanders, P., additional, Morton, J., additional, Kalman, J., additional, and Kistler, P., additional

Published
2015
Full Text
View/download PDF

40. A Minimal or Maximal Ablation Strategy to Achieve Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Acute Outcomes in a Prospective Multi-Centre Randomised Controlled Trial (The Minimax Study)

Author

McLellan, A., primary, Ling, L., additional, Lee, G., additional, Azzopardi, S., additional, Kumar, S., additional, Wong, M., additional, Lee, J., additional, Walters, T., additional, Looi, K., additional, Stiles, M., additional, Lever, N., additional, Fynn, S., additional, Heck, P., additional, Sanders, P., additional, Morton, J., additional, Kalman, J., additional, and Kistler, P., additional

Published
2013
Full Text
View/download PDF

42. Pulmonary Vein Isolation Requiring Ablation on the Intervenous Ridge to Achieve Electrical Disconnection: Impact on Acute and Long Term Outcome

Author

McLellan, A., primary, Ling, L., additional, Lee, G., additional, Azzopardi, S., additional, Kumar, S., additional, Wond, M., additional, Lee, J., additional, Walters, T., additional, Looi, K., additional, Stiles, M., additional, Lever, N., additional, Fynn, S., additional, Heck, P., additional, Sanders, P., additional, Morton, J., additional, Kalman, J., additional, and Kistler, P., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results